IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
Life review of elderly depression
Development and application of ATR-FTIR spectroscopy for mixture homogeneity in pharmaceutical application
The Increasing Damage in Tubular Cell of Infant Mice’s Kidneys from Carbofuran Exposure during its Mothers’ Lactation Period
Trend of transsexualism problem and its implications towards muslim community in Malaysia
Development and validation of RP-HPLC method for the estimation of pidotimod in tablet dosage form
Evaluation of neurotoxicity of the ethanolic bark extract of Holarrhena pubescens Wall. ex G.Don in mice
Design, synthesis and evaluation of 2-aminobenzimidazole derivatives: strong candidate for PPAR gamma agonists.
Prediction of Heart Disease Using Feature Selection and Random Forest Ensemble Method
Strategies for Antiviral Drugs from Plants by Targeting the Hemagglutinin, Neuraminidase and other receptors of Influenza A virus
The impact of human resource and quality management in health care: A Review
123456789
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Stability Indicating RP-HPLC Method for the Estimation of Plerixafor and its

Author: PINGALI SRIDEVI, VINUTHA.K, MAHESH.K, AKSHITHA.M, BHAGAVAN RAJU.M , KEERTHI CHAND
Abstract: Developed and validated a stability indicating reversed phase high performance liquid chromatographic method (RPHPLC) for the estimation of plerixafor and its impurities in bulk and parenteral dosage form. The method was carried out using Zorbax eclipse C18 column (250 x 4.6mm, 5?m) with mobile phase-A and mobile phase-B, where mobile phase-A consists of 1-Hexane sulphonic acid sodium salt buffer and mobile phase-B consists of Acetonitrile and water in the ratio of 80:20 (v/v) under gradient mode with an injection volume of 10µL at flow rate of 1ml/min and the detection was carried out at 210 nm. The retention time of the plerixafor for assay and RS method were found to be 14.17min and 21.68min. The assay method showed linear response in the concentration range of 200-600µg/ml with a correlation coefficient of 0.999 and for RS method in the concentration range of LOQ to 200% with a correlation coefficient of 0.998. The method precision for the determination of assay was below 2% RSD and the percentage recovery of plerixafor was found to be 99.47. Plerixafor was subjected to stress conditions like acidic, alkaline and oxidation degradations. The degradation products were well separated from each other and with the main peak. The proposed method was validated as per ICH guidelines. The method was found to be linear, specific, precise and accurate. Therefore, the proposed method can be used for the routine analysis of drug in the process control of bulk and pharmaceutical formulation.
Keyword: Plerixafor, Potential impurities, RP-HPLC, Validation, Stability indicating
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free